FIELD: medicine.
SUBSTANCE: invention relates to field of biotechnology and can be used to study processes of biopathogen distribution in environment, to investigate ability of substances of protein nature to penetrate into units of water-purifying installations and to predict stability of protein contaminations in water medium and on environment object surfaces. Method of controlling distribution and stability of biological admixtures of protein nature in environment includes application of biotracer with ice-forming activity onto investigated object and registration of said activity in samples collected in various space-time points. As biotracer material purified protein substance with ice-forming activity obtained from cells of bacteria Erwinia herbicola, Pseudomonas syringae, Pseudomonas fluorescens is used.
EFFECT: application of invention allows to characterise distribution and stability in environment of substances similar to protein toxins and differing in molecular weight and stability to action of inactivating factors of environment.
2 dwg, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INDICATION OF BIOCIDE ACTIVITY OF PEROXIDE DISINFECTING SOLUTIONS TO BOTULINIC NEUROTOXIN | 2003 |
|
RU2265057C2 |
METHOD OF AEROSOL FILTER PERMEABILITY TEST AS FOR MICROORGANISMS | 2006 |
|
RU2327142C1 |
METHOD FOR PRODUCTION OF POWDERED ICE-FORMING BIOLOGICAL REAGENT | 2010 |
|
RU2440780C1 |
METHOD OF DETERMINATION OF CONCENTRATION OF INSECTICIDE METAPHOS AND PRODUCT OF HYDROLYSIS OF ORGANOPHOSPHORUS NITRO-AROMATIC INSECTICIDES OF PARA-NITROPHENOL IN AQUEOUS MEDIUM | 2000 |
|
RU2175352C1 |
EXPERIMENTAL METHOD FOR ELIMINATION OF PATHOGENIC AND OPPORTUNISTIC MICROORGANISMS | 2012 |
|
RU2500430C1 |
LIQUID NUTRIENT MEDIUM FOR SUBMERGED CULTURING MICROORGANISM PLESIOMONAS SHIGELLOIDES, STRAIN 16 | 2002 |
|
RU2239654C2 |
PHARMACEUTICAL SUBSTANCE FOR TREATING INFECTED WOUNDS OF VARIOUS ORIGINS | 2018 |
|
RU2687102C1 |
IMMUNOENZYMOMETRIC TEST SYSTEM FOR SEROLOGIC DIAGNOSIS OF REOVIRUS INFECTION IN CATTLE AND MONITORING OF POST-VACCINATION IMMUNITY LEVEL | 2011 |
|
RU2488117C2 |
BACTERICIDAL PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION IN THE FORM OF AN ENDOLYSIN-CONTAINING BACTERICIDAL GEL | 2021 |
|
RU2781050C1 |
STRAIN OF CULTIVATED HYBRID ANIMAL CELLS MUS MUSCULUS L BPM VD-10 - PRODUCER OF MONOCLONAL ANTIBODY 5H/E TO ANTIGEN KDA 200 OF MELIOIDOSIS PATHOGEN | 2014 |
|
RU2570638C1 |
Authors
Dates
2009-05-10—Published
2007-10-09—Filed